4-(hydroxy(1-methyl-1H-imidazol-5-yl)methyl)-2-iodobenzonitrile | 371764-77-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(hydroxy(1-methyl-1H-imidazol-5-yl)methyl)-2-iodobenzonitrile
• 英文别名: 4-[Hydroxy-(3-methylimidazol-4-yl)methyl]-2-iodobenzonitrile
• CAS: 371764-77-1
• 化学式: C₁₂H₁₀IN₃O
• 分子量: 339.135
• InChiKey: YMSRQOLDFHJKKE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  61.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(hydroxy(1-methyl-1H-imidazol-5-yl)methyl)-2-iodobenzonitrile 、 5-(3-chlorophenyl)-6-(hydroxymethyl)-1-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile 在 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 生成 5-(3-Chloro-phenyl)-6-[(4-cyano-3-iodo-phenyl)-(3-methyl-3H-imidazol-4-yl)-methoxymethyl]-1-methyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile
  参考文献：
  名称：

  Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation

  摘要：

  Farnesyltransferase inhibitors (FTIs) have been developed as potential anti-cancer agents due to their efficacy in blocking malignant growth in a variety of murine models of human tumors. To that end, we have developed a series of pyridone farnesyltransferase inhibitors with potent in vitro and cellular activity. The synthesis, SAR and biological properties of these compounds will be discussed. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.08.058
• 作为产物：
  描述：

  1-methyl-2-triethylsilanyl-1H-imidazole 、 4-formyl-2-iodobenzonitrile 在 叔丁基锂 作用下， 以 四氢呋喃 为溶剂， 生成 4-(hydroxy(1-methyl-1H-imidazol-5-yl)methyl)-2-iodobenzonitrile
  参考文献：
  名称：

  Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation

  摘要：

  Farnesyltransferase inhibitors (FTIs) have been developed as potential anti-cancer agents due to their efficacy in blocking malignant growth in a variety of murine models of human tumors. To that end, we have developed a series of pyridone farnesyltransferase inhibitors with potent in vitro and cellular activity. The synthesis, SAR and biological properties of these compounds will be discussed. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.08.058

文献信息

• Substituted phenyl farnesyltransferase inhibitors
  申请人：——

  公开号：US20020019527A1

  公开（公告）日：2002-02-14

  Compounds of formula (I) 1 or pharmaceutically acceptable salts thereof, inhibit farnesyltransferase. Methods for making the compounds, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds are disclosed.

  式(I)的化合物或其药学上可接受的盐，抑制法尼基转移酶。公开了制备这些化合物的方法，含有这些化合物的药物组合物，以及使用这些化合物进行治疗的方法。